148 related articles for article (PubMed ID: 7504734)
1. Nonprostanoid prostacyclin mimetics. 5. Structure-activity relationships associated with [3-[4-(4,5-diphenyl-2-oxazolyl)-5- oxazolyl]phenoxy]acetic acid.
Meanwell NA; Romine JL; Rosenfeld MJ; Martin SW; Trehan AK; Wright JJ; Malley MF; Gougoutas JZ; Brassard CL; Buchanan JO
J Med Chem; 1993 Nov; 36(24):3884-903. PubMed ID: 7504734
[TBL] [Abstract][Full Text] [Related]
2. Nonprostanoid prostacyclin mimetics. 4. Derivatives of 2-[3-[2-(4,5-diphenyl-2-oxazolyl)ethyl]phenoxy]acetic acid substituted alpha to the oxazole ring.
Meanwell NA; Rosenfeld MJ; Wright JJ; Brassard CL; Buchanan JO; Federici ME; Fleming JS; Gamberdella M; Hartl KS; Zavoico GB
J Med Chem; 1993 Nov; 36(24):3871-83. PubMed ID: 8254619
[TBL] [Abstract][Full Text] [Related]
3. Nonprostanoid prostacyclin mimetics. 3. Structural variations of the diphenyl heterocycle moiety.
Meanwell NA; Rosenfeld MJ; Trehan AK; Romine JL; Wright JJ; Brassard CL; Buchanan JO; Federici ME; Fleming JS; Gamberdella M
J Med Chem; 1992 Sep; 35(19):3498-512. PubMed ID: 1404231
[TBL] [Abstract][Full Text] [Related]
4. Nonprostanoid prostacyclin mimetics. 2. 4,5-Diphenyloxazole derivatives.
Meanwell NA; Rosenfeld MJ; Trehan AK; Wright JJ; Brassard CL; Buchanan JO; Federici ME; Fleming JS; Gamberdella M; Zavoico GB
J Med Chem; 1992 Sep; 35(19):3483-97. PubMed ID: 1404230
[TBL] [Abstract][Full Text] [Related]
5. Non-prostanoid prostacyclin mimetics. 6. Derivatives of 2-[3-[2-(4,5-Diphenyl-2-oxazolyl)ethyl]phenoxy]acetic acid modified beta-to the oxazole ring.
Meanwell NA; Rosenfeld MJ; Trehan AK; Wright JJ; Brassard CL; Buchanan JO; Federici ME; Fleming JS; Gamberdella M; Hartl KS
Drug Des Discov; 1994 Jan; 11(1):73-89. PubMed ID: 7520762
[TBL] [Abstract][Full Text] [Related]
6. Relaxant actions of nonprostanoid prostacyclin mimetics on human pulmonary artery.
Jones RL; Qian YM; Wise H; Wong HN; Lam WL; Chan HW; Yim AP; Ho JK
J Cardiovasc Pharmacol; 1997 Apr; 29(4):525-35. PubMed ID: 9156364
[TBL] [Abstract][Full Text] [Related]
7. [3-[4-(4,5-Diphenyl-2-oxazolyl)-5-oxazolyl]phenoxy]acetic acid (BMY 45778) is a potent non-prostanoid prostacyclin partial agonist: effects on platelet aggregation, adenylyl cyclase, cAMP levels, protein kinase, and iloprost binding.
Seiler SM; Brassard CL; Federici ME; Romine J; Meanwell NA
Prostaglandins; 1997 Jan; 53(1):21-35. PubMed ID: 9068064
[TBL] [Abstract][Full Text] [Related]
8. Structure-activity relationships associated with 3,4,5-triphenyl-1H-pyrazole-1-nonanoic acid, a nonprostanoid prostacyclin mimetic.
Meanwell NA; Rosenfeld MJ; Wright JJ; Brassard CL; Buchanan JO; Federici ME; Fleming JS; Seiler SM
J Med Chem; 1992 Jan; 35(2):389-97. PubMed ID: 1370696
[TBL] [Abstract][Full Text] [Related]
9. 2-[3-[2-(4,5-Diphenyl-2-oxazolyl) ethyl] phenoxy] acetic acid (BMY 42393): a new, structurally-novel prostacyclin partial agonist: 1). Inhibition of platelet aggregation and mechanism of action.
Seiler SM; Brassard CL; Federici ME; Buchanan JO; Zavoico GB; Fleming JS; Meanwell NA
Thromb Res; 1994 Apr; 74(2):115-23. PubMed ID: 8029812
[TBL] [Abstract][Full Text] [Related]
10. A study of prostacyclin mimetics distinguishes neuronal from neutrophil IP receptors.
Wise H; Qian YM; Jones RL
Eur J Pharmacol; 1995 May; 278(3):265-9. PubMed ID: 7589166
[TBL] [Abstract][Full Text] [Related]
11. Functional and ligand binding studies suggest heterogeneity of platelet prostacyclin receptors.
Armstrong RA; Lawrence RA; Jones RL; Wilson NH; Collier A
Br J Pharmacol; 1989 Jul; 97(3):657-68. PubMed ID: 2474350
[TBL] [Abstract][Full Text] [Related]
12. A novel pyridazinone derivative as a nonprostanoid PGI2 agonist.
Tsubaki K; Taniguchi K; Tabuchi S; Okitsu O; Hattori K; Seki J; Sakane K; Tanaka H
Bioorg Med Chem Lett; 2000 Dec; 10(24):2787-90. PubMed ID: 11133092
[TBL] [Abstract][Full Text] [Related]
13. Octimibate, a potent non-prostanoid inhibitor of platelet aggregation, acts via the prostacyclin receptor.
Merritt JE; Hallam TJ; Brown AM; Boyfield I; Cooper DG; Hickey DM; Jaxa-Chamiec AA; Kaumann AJ; Keen M; Kelly E
Br J Pharmacol; 1991 Jan; 102(1):251-9. PubMed ID: 1710526
[TBL] [Abstract][Full Text] [Related]
14. Prostaglandin endoperoxide analogues which are both thromboxane receptor antagonists and prostacyclin mimetics.
Armstrong RA; Jones RL; MacDermot J; Wilson NH
Br J Pharmacol; 1986 Mar; 87(3):543-51. PubMed ID: 3026540
[TBL] [Abstract][Full Text] [Related]
15. Comparison of inhibitory actions of prostacyclin and a new prostacyclin analogue on the aggregation of human platelet in whole blood.
Saniabadi AR; Belch JJ; Lowe GD; Barbenel JC; Forbes CD
Haemostasis; 1987; 17(3):147-53. PubMed ID: 2440771
[TBL] [Abstract][Full Text] [Related]
16. Replacing the cyclohexene-linker of FR181157 leading to novel IP receptor agonists: orally active prostacyclin mimetics. Part 6.
Tanaka A; Hattori K; Taniguchi K; Okitsu O; Tabuchi S; Nishio M; Nagakura Y; Maeda N; Murai H; Seki J
Bioorg Med Chem Lett; 2006 Sep; 16(18):4861-4. PubMed ID: 16837197
[TBL] [Abstract][Full Text] [Related]
17. Primate vascular responses to octimibate, a non-prostanoid agonist at the prostacyclin receptor.
Merritt JE; Brown AM; Bund S; Cooper DG; Egan JW; Hallam TJ; Heagerty AM; Hickey DM; Kaumann AJ; Keen M
Br J Pharmacol; 1991 Jan; 102(1):260-6. PubMed ID: 2043927
[TBL] [Abstract][Full Text] [Related]
18. Interphenylene 7-oxabicyclo[2.2.1]heptane oxazoles. Highly potent, selective, and long-acting thromboxane A2 receptor antagonists.
Misra RN; Brown BR; Sher PM; Patel MM; Hall SE; Han WC; Barrish JC; Kocy O; Harris DN; Goldenberg HJ
J Med Chem; 1993 May; 36(10):1401-17. PubMed ID: 8496908
[TBL] [Abstract][Full Text] [Related]
19. Comparison of anti-aggregatory effects of PGI2, PGI3 and iloprost on human and rabbit platelets.
Kobzar G; Mardla V; Järving I; Samel N
Cell Physiol Biochem; 2001; 11(5):279-84. PubMed ID: 11684817
[TBL] [Abstract][Full Text] [Related]
20. Piperidine derivatives as nonprostanoid IP receptor agonists 2.
Hayashi R; Ito H; Ishigaki T; Morita Y; Miyamoto M; Isogaya M
Bioorg Med Chem Lett; 2016 Jun; 26(12):2886-2889. PubMed ID: 27133594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
